Literature DB >> 26061320

Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.

Isabela C Watanabe1, Renata F Magalhães, Aparecida M de Moraes, Rafael F Stelini, Geórgia F Cintra, Konradin Metze, Maria L Cintra.   

Abstract

Differential diagnosis between keratoacanthoma (KA) and squamous cell carcinoma (SCC) is difficult due to their similarities. The mechanisms that drive their distinct biological behavior are poorly understood. To investigate whether the assessment of microvessel density (MVD) could be helpful in KA and SCC differential diagnosis and to gain insight into the pathogenesis of KA-like neoplasms, we compared the density of CD105- and CD34-stained vessels in KAs and SCCs and their relation to the expression of the p53 oncoprotein and proliferation marker Ki67. This is an observational retrospective cohort study. Forty lesions with clinical appearance of KAs (29 KAs and 11 SCCs) entered the study. A biopsy was taken from each lesion at presentation and the natural clinical course was monitored for at least 1 month. Growing or minimally regressing lesions were submitted to complete surgical excision. The diagnoses were established on combined clinical, histological, and follow-up evaluations. The MVD and p53 or Ki67 expression in neoplastic cells were assessed through morphometry. The MVD did not show discriminating power between KAs and SCCs. The Ki67 proliferation rate was significantly higher in SCCs. Although neoangiogenesis (CD105-MVD) in KAs was associated with cell proliferation, in SCCs it was not. There was significant correlation between p53 expression and neoplasia size in SCCs but not in KAs. From our results, we may conclude that KA and SCC have similarities, as CD105- and CD34-MVD. However, the low Ki67 proliferation index and the positive correlation between Ki-67 index and neovascularization in KA suggest a dependence in neovascularization to grow in KA, pointing to involvement of distinct pathogenesis.

Entities:  

Mesh:

Year:  2015        PMID: 26061320      PMCID: PMC4616484          DOI: 10.1097/MD.0000000000000934

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  28 in total

1.  Keratoacanthomas frequently show chromosomal aberrations as assessed by comparative genomic hybridization.

Authors:  Ole Petter F Clausen; Marzieh Beigi; Lars Bolund; Steen Kølvraa; Petter Jensen Gjersvik; Gro Mørk; Paula M de Angelis
Journal:  J Invest Dermatol       Date:  2002-12       Impact factor: 8.551

Review 2.  Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases.

Authors:  E Hodak; R E Jones; A B Ackerman
Journal:  Am J Dermatopathol       Date:  1993-08       Impact factor: 1.533

3.  A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues.

Authors:  J M Wang; S Kumar; D Pye; A J van Agthoven; J Krupinski; R D Hunter
Journal:  Int J Cancer       Date:  1993-05-28       Impact factor: 7.396

4.  Utility of peanut agglutinin (PNA) in the diagnosis of squamous cell carcinoma and keratoacanthoma.

Authors:  G Kannon; H K Park
Journal:  Am J Dermatopathol       Date:  1990-02       Impact factor: 1.533

5.  Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression.

Authors:  H Takeda; S Kondo
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

Review 6.  Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies.

Authors:  E Fonsatti; L Sigalotti; P Arslan; M Altomonte; M Maio
Journal:  Curr Cancer Drug Targets       Date:  2003-12       Impact factor: 3.428

7.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Authors:  N Weidner; P R Carroll; J Flax; W Blumenfeld; J Folkman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

8.  The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study.

Authors:  A Srivastava; P Laidler; R P Davies; K Horgan; L E Hughes
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

9.  Diagnosis and follow-up of keratoacanthoma-like lesions: clinical-histologic study of 43 cases.

Authors:  Renata Ferreira Magalhães; Gabriela Torres Cruvinel; Geórgia Fontes Cintra; Maria Letícia Cintra; Ana Paula Palu Baltieri Ismael; Aparecida Machado de Moraes
Journal:  J Cutan Med Surg       Date:  2008 Jul-Aug       Impact factor: 2.092

10.  Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy.

Authors:  F J Burrows; E J Derbyshire; P L Tazzari; P Amlot; A F Gazdar; S W King; M Letarte; E S Vitetta; P E Thorpe
Journal:  Clin Cancer Res       Date:  1995-12       Impact factor: 12.531

View more
  3 in total

1.  Patterns of LC3A Autophagy Protein Expression in Keratoacanthomas.

Authors:  Efthimios Sivridis; Ioannis M Koukourakis; Stella Arelaki; Kostantina Balaska; Antonios Karpouzis; Alexandra Giatromanolaki
Journal:  Head Neck Pathol       Date:  2019-04-11

2.  Cytokeratin 17 and Ki-67: Immunohistochemical markers for the differential diagnosis of keratoacanthoma and squamous cell carcinoma.

Authors:  Cem Leblebici; Esra Pasaoglu; Canan Kelten; Seher Darakci; Nevra Dursun
Journal:  Oncol Lett       Date:  2017-03-01       Impact factor: 2.967

3.  An Analysis of Biopsies for Suspected Skin Cancer at a Tertiary Care Dermatology Clinic in the Western Cape Province of South Africa.

Authors:  Johann de Wet; Minette Steyn; Henry F Jordaan; Rhodine Smith; Saskya Claasens; Willem I Visser
Journal:  J Skin Cancer       Date:  2020-01-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.